BOLA1: Potential Drug Target Or Biomarker (G51027)

Target Name: BOLA1

NCBI ID: G51027

BOLA1

BOLA1: Potential Drug Target Or Biomarker

BOLA1 (BOLA1 variant 2) is a protein that is expressed in various tissues throughout the body, including the brain, heart, lungs, and liver. It is a component of the B cell lineage, which is responsible for producing antibodies as a response to foreign substances in the body. BOLA1 plays a crucial role in the development and maintenance of the immune system, and is also involved in the regulation of cellular processes that are essential for the survival and function of all cells.

Recent studies have identified BOLA1 as a potential drug target or biomarker, with potential therapeutic applications in a variety of diseases. In this article, we will explore the biology and function of BOLA1, as well as its potential as a drug target or biomarker.

BOLA1 is a transmembrane protein that is expressed in a variety of tissues throughout the body, including the brain, heart, lungs, and liver. It is a member of the B cell lineage and is involved in the development and regulation of the immune system. BOLA1 is typically produced in the bone marrow and thymus, and it is expressed in the plasma and various tissues throughout the body.

One of the key functions of BOLA1 is its role in the regulation of cellular processes that are essential for the survival and function of all cells. BOLA1 is involved in the development and maintenance of the blood-brain barrier, which is a barrier that separates the brain from the surrounding blood vessels and is designed to protect the brain from harmful substances and diseases. BOLA1 is also involved in the regulation of cell division and the development of tissues, as well as in the regulation of cellular signaling pathways that are essential for the survival and function of all cells.

In addition to its role in the immune system and cellular processes, BOLA1 is also potential as a drug target or biomarker. Several studies have identified BOLA1 as a potential drug target, based on its involvement in cellular processes that are important for the development and maintenance of the immune system. In addition, BOLA1 has also been identified as a potential biomarker, based on its expression in various tissues and its involvement in the regulation of cellular processes that are essential for the survival and function of all cells.

One of the potential therapeutic applications of BOLA1 as a drug target is its potential to treat autoimmune diseases, such as multiple sclerosis and rheumatoid arthritis. These diseases are characterized by the immune system attacking the body's own tissues, leading to inflammation and damage. BOLA1 is involved in the regulation of cellular processes that are essential for the development and maintenance of the immune system, and it is possible that targeting BOLA1 may be a effective way to treat autoimmune diseases.

Another potential therapeutic application of BOLA1 as a drug target is its potential to treat cancer. Cancer is a disease that is characterized by the uncontrolled growth and division of cells, leading to the formation of tumors. BOLA1 is involved in the regulation of cellular processes that are essential for the survival and function of all cells, and it is possible that targeting BOLA1 may be a effective way to treat cancer.

In addition to its potential therapeutic applications, BOLA1 has also potential as a biomarker in the diagnosis and monitoring of various diseases. Its expression in various tissues and its involvement in the regulation of cellular processes that are essential for the survival and function of all cells make it an attractive candidate for use as a biomarker in a variety of diseases.

In conclusion, BOLA1 is a protein that is expressed in various tissues throughout the body and is involved in the development and maintenance of the immune system. Its role in the regulation of cellular processes that are essential for the survival and function of all cells makes it a potential drug target or biomarker in a variety of diseases. Further research is needed to fully understand the biology and function of BOLA1 and its potential as a drug target or biomarker.

Protein Name: BolA Family Member 1

Functions: Acts as a mitochondrial iron-sulfur (Fe-S) cluster assembly factor that facilitates (Fe-S) cluster insertion into a subset of mitochondrial proteins (By similarity). Probably acts together with the monothiol glutaredoxin GLRX5 (PubMed:27532772). May protect cells against oxidative stress (PubMed:22746225)

The "BOLA1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BOLA1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets